Back to search results

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Pancreatic Cancer · Adenocarcinoma of the Pancreas · Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Columbia University Irving Medical Center, New York, New York, United States

    Contact: Study coordinator (Research Nurse Navigator) · cancerclinicaltrials@cumc.columbia.edu · 212-342-5162
    Contact: Principal Investigator (Gulam Manji, MD, PhD)

  • Brown University, Providence, Rhode Island, United States

    Contact: Study coordinator (Alexander Raufi, MD) · ARaufi@Lifespan.org · 18442222881
    Contact: Principal Investigator (Alexander Raufi, MD)

  • Medical College of Wisconsin, Wisconsin Diagnostic Labratories, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Mandana Kamgar, MD) · mkamgar@mcw.edu · 414-805-0505
Study leads

  • Gulam Manji, MD,PhD

    Principal Investigator

    Columbia University

View source on ClinicalTrials.gov(opens in a new tab)